Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$498M |
| 2 |
Micron Technology
MU
|
+$374M |
| 3 |
Amazon
AMZN
|
+$356M |
| 4 |
Accenture
ACN
|
+$318M |
| 5 |
Advanced Micro Devices
AMD
|
+$301M |
Top Sells
| 1 |
Apple
AAPL
|
+$684M |
| 2 |
Meta Platforms (Facebook)
META
|
+$630M |
| 3 |
Tesla
TSLA
|
+$595M |
| 4 |
Chevron
CVX
|
+$497M |
| 5 |
Shopify
SHOP
|
+$439M |
Sector Composition
| 1 | Healthcare | 19.38% |
| 2 | Technology | 18.55% |
| 3 | Consumer Staples | 10.17% |
| 4 | Consumer Discretionary | 9.68% |
| 5 | Financials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Northeast Community Bancorp
NECB
$267M
| $809K | ﹤0.01% |
65,241
-1,659
| -2% | -$20.6K |
|
2627
Taysha Gene Therapies
TSHA
$824M
| $808K | ﹤0.01% |
418,500
-105,100
| -20% | -$203K |
|
2628
VanEck Agribusiness ETF
MOO
$622M
| $807K | ﹤0.01% |
+10,000
| New | +$807K |
|
2629
Q2 Holdings
QTWO
$5.18B
| $805K | ﹤0.01% |
25,000
+9,200
| +58% | +$296K |
|
2630
Aligos Therapeutics
ALGS
$65.1M
| $804K | ﹤0.01% |
29,224
-6,900
| -19% | -$190K |
|
|
CHCT
2631
Community Healthcare Trust
CHCT
$438M
| $802K | ﹤0.01% |
24,500
-73,400
| -75% | -$2.4M |
|
|
NOAH
2632
Noah Holdings
NOAH
$771M
| $799K | ﹤0.01% |
60,500
-9,400
| -13% | -$124K |
|
2633
Corvus Pharmaceuticals
CRVS
$438M
| $798K | ﹤0.01% |
975,519
+12,587
| +1% | +$10.3K |
|
|
INFI
2634
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $798K | ﹤0.01% |
670,612
-90,552
| -12% | -$108K |
|
2635
Outset Medical
OM
$244M
| $795K | ﹤0.01% |
+3,327
| New | +$795K |
|
2636
Lightpath Technologies
LPTH
$296M
| $794K | ﹤0.01% |
741,700
-70,700
| -9% | -$75.7K |
|
2637
Vanguard Global ex-US Real Estate ETF
VNQI
$3.64B
| $794K | ﹤0.01% |
20,800
+8,000
| +63% | +$305K |
|
2638
IAC Inc
IAC
$2.89B
| $793K | ﹤0.01% |
+17,465
| New | +$793K |
|
2639
Kopin
KOPN
$366M
| $793K | ﹤0.01% |
755,675
-347,764
| -32% | -$365K |
|
2640
Banco Macro
BMA
$2.71B
| $792K | ﹤0.01% |
55,472
+43,472
| +362% | +$621K |
|
2641
Hennessy Advisors
HNNA
$91.7M
| $789K | ﹤0.01% |
90,975
-14,600
| -14% | -$127K |
|
2642
iShares Core 60/40 Balanced Allocation ETF
AOR
$2.75B
| $788K | ﹤0.01% |
17,595
-11,605
| -40% | -$520K |
|
2643
Stoneridge
SRI
$230M
| $788K | ﹤0.01% |
46,519
-14,900
| -24% | -$252K |
|
2644
Scansource
SCSC
$985M
| $787K | ﹤0.01% |
+29,810
| New | +$787K |
|
|
TECX
2645
Tectonic Therapeutic, Inc. Common Stock
TECX
$310M
| $785K | ﹤0.01% |
101,845
-27,805
| -21% | -$214K |
|
2646
Marten Transport
MRTN
$949M
| $784K | ﹤0.01% |
40,900
-254,750
| -86% | -$4.88M |
|
2647
CureVac
CVAC
$1.21B
| $783K | ﹤0.01% |
+99,348
| New | +$783K |
|
|
LOAN
2648
Manhattan Bridge Capital
LOAN
$60.7M
| $781K | ﹤0.01% |
138,428
-37,413
| -21% | -$211K |
|
|
BFX
2649
DELISTED
BowFlex Inc.
BFX
| $781K | ﹤0.01% |
479,100
-673,683
| -58% | -$1.1M |
|
2650
Digi International
DGII
$1.33B
| $778K | ﹤0.01% |
22,500
-25,300
| -53% | -$875K |
|